Table 1.
Patients’ characteristics and clinical outcomes.
| Variables | |
|---|---|
| Age, mean (SD), years | 63.0 (15.3) |
| Men, No. (%) | 276 (58.1) |
| Comorbidities occurrence* | |
| Diabetes, No. (%) | 128 (26.9%) |
| Hypertension, No. (%) | 259 (54.5%) |
| Cardiovascular disease, No. (%) | 124 (26.1%) |
| Chronic kidney disease, No. (%) | 48 (10.1%) |
| Tumor, No. (%) | 29 (6.1%) |
| Smoking, No. (%)* | |
| Never | 421 (88.6%) |
| Former | 32 (6.7%) |
| Current | 21 (4.4%) |
| Hospitalization course | |
| The number of days in hospital, mean (SD), days | 20.3 (15.5) |
| Transferring the patient to ICU, No. (%) | 103 (21.7%) |
| Tracheostomy, No. (%) | 47 (9.9%) |
| Intubation during hospitalization, No. (%) | 98 (20.6%) |
| Shock during hospitalization, No. (%) | 89 (18.7%) |
| Deterioration of the patient’s condition during hospital stay, No. (%) | 172 (36.2%) |
| Initiation of renal replacement therapy, No. (%) | 41 (8.6%) |
| SIRS, No. (%) | 65 (13.7%) |
| Death in hospital, No. (%) | 96 (20.2%) |
| Laboratory values | |
| 25(OH)D, ng/ml (Me, IQR) | 20.55 (20.30) |
| Creatinine, mg/dl (Me, IQR) | 0.95 (0.44) |
| CRP, mg/l (Me, IQR) | 61.18 (101.29) |
| IL-6, pg/mL (Me, IQR) | 21.85 (43.15) |
* data from the interview with the patient on admission; SD, standard deviation; No., number; ICU, Intensive Care Unit; SIRS, systematic inflammatory response syndrome; 25(OH)D, 25-hydroxyvitamin D; CRP, C-reactive protein, IL-6, Interleukin-6, Me, median; IQR, interquartile range.